Addition of Tocilizumab to Cyclosporine/ MMF for Acute Graft-Vs-Host Disease (aGVHD) Prophylaxis in Adult Double Unit Cord Blood Transplant (dCBT) Recipients: Promising Preliminary Results of a Phase II Clinical Trial.
2019 ◽
Vol 25
(3)
◽
pp. S226-S227
Keyword(s):
Phase Ii
◽